Localized scleroderma (morphea);Sclérodermies localisées ou morphées

Presse Medicale

Volumn 35, Issue 12 C2, 2006, Pages 1923-1928

  Bono, Waafa ^a   Dupin, Nicolas ^a  

^a Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE;

CLINICAL EXAMINATION; CLINICAL FEATURE; HUMAN; MORPHEA; PROGNOSIS; REVIEW; SCLERODERMA; SKIN DEFECT; SKIN MANIFESTATION; SKIN PENETRATION; SYMPTOM; SYSTEMIC SCLEROSIS; TREATMENT PLANNING;

EID: 33845479894     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(06)74926-0     Document Type: Review

References (17)

1. Peterson LS, Nelson AM, Su WP, Mason T, O'Fallon WM, Gabriel SE. The epidemiology of morphea (localized scleroderma) in Olmsted county 1960-1993. J Rheumatol. 1997; 24: 73-80.
2. Peterson LS, Nelson AM, Su WP. Classification of morphea. Mayo Clin Proc. 1995; 70: 1068-76.
3. Marzano AV, Menni S, Parodi A, Borghi A, Fuligimi A, Fabbri P et al. Localized scleroderma in adults and children. Clinical and laboratory investigations of 239 cases. Eur J Dermatol. 2003; 13: 171-6.
4. Dehen L, Roujeau JC, Cosnes A, Revuz J. Internal involvement in loclaized scleroderma. Medicine. 1994; 73: 241-5.
5. Raguin G, Boisnic S, Souteyrand P, Baranton G, Piette JC, Godeau P et al. No evidence for spirochaetal origin of localized scleroderma. Br J Dermatol. 1992; 127: 218-20.
6. Takehara K, Sato S. Localized scleroderma is an autoimmune disorder. Rheumatology. 2005; 44: 274-9.
7. Hawk A, English III JC. Localized and systemic scleroderma. Sem Cutan Med Surg. 2001; 20: 27-37.
8. Torres JE, Sanchez JL. Histopathologic differentiation between localized and systemic scleroderma. Am J Dermatopathol. 1998; 20: 242-5.
9. Sehgal VN, Srivastava G, Aggarwal AK, Behl PN, Choudhary M, Bajaj P. Localized scleroderma/morphea. Intern J Dermatol. 2002; 41: 467-75.
10. Hayakawa I, Hasegawa M, Takehara K, Sato S. Anti-DNA topoisomerase II autoantibodies in localized scleroderma. Arthritis Rheum. 2004; 50: 227-32.
11. Sapadin AN, Fleischmajer R. Treatment of scleroderma. Arch Dermatol. 2002; 138: 99-105.
12. Cunningham BB, Landells IDR, Langman C, Sailer DE, Paller AS. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol. 1998; 39: 211-5.
13. Mancuso G, Berdondini RM. Topical tacrolimus in the treatment of localized scleroderma. Eur J Dermatol. 2003; 13: 590-2.
14. Hoffmann K, Gerbaulet U, el-Gammal S, Altmeyer P. 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea). Acta Derm Venereol (Stockh). 1991; 164: 3-16.
15. Kerscher M, Meurer M, Sander C, Volkenandt M, Lehmann P, Plewig G et al. PUVA-bath photochemotherapy for localized scleroderma. Arch Dermatol. 1996; 132: 1280-2.
16. Kerscher M, Volkenandt M, Gruss C, Reuther T, Von Kobyletzki G, Freitag M et al. Low-dose phototherapy for treatment of localized scleroderma. J Am Acad Dermatol. 1998; 38: 21-6.
17. Kreuter A, Gambichler T, Breuckmann F, Rotterdam S, Freitag M, Stuecker M. Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma. Arch Dermatol. 2005; 141: 847-52.